MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Janux Therapeutics (JANX) Ownership - Who owns Janux Therapeutics?

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
801.33M
P/E Ratio
N/A
Total Cash
956.39M
Projected Growth
N/A
Total Debt
21.57M
Revenue
13.73M
Risk (Beta)
3.49
Dividend Yield
N/A
Total Cash/Share
15.68
Total Debt/Equity
N/A
Revenue/Share
0.22 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
JANX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for JANX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com